2024-03-28T14:13:37Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_56AFF9065EE0
2024-03-23T02:23:49Z
serval:BIB_56AFF9065EE0
Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study.
10.1016/S2352-3018(15)00027-2
26424673
000363792300008
Molina
J.M.
author
Clotet
B.
author
van Lunzen
J.
author
Lazzarin
A.
author
Cavassini
M.
author
Henry
K.
author
Kulagin
V.
author
Givens
N.
author
de Oliveira
C.F.
author
Brennan
C.
author
FLAMINGO study team
contributor
Khuong-Josses
MA.
contributor
Molina
JM.
contributor
Pialoux
G.
contributor
Raffi
F.
contributor
Reynes
J.
contributor
Yeni
P.
contributor
Kern
W.
contributor
Stephan
C.
contributor
Van Lunzen
J.
contributor
Antinori
A.
contributor
D'Arminio Monforte
A.
contributor
Di Perri
G.
contributor
Guaraldi
G.
contributor
Lazzarin
A.
contributor
Melendez-Rivera
I.
contributor
Morales Ramirez
J.
contributor
Santana-Bagur
J.
contributor
Duiculescu
D.
contributor
Preotescu
L.
contributor
Rugina
S.
contributor
Kozyrev
O.
contributor
Kulagin
V.
contributor
Pokrovskiy
V.
contributor
Shuldyakov
A.
contributor
Voronin
E.
contributor
Clotet
B.
contributor
Gatell
J.
contributor
Podzamczer
D.
contributor
Rubio
R.
contributor
Viciana
P.
contributor
Cavassini
M.
contributor
Fehr
J.
contributor
Furrer
H.
contributor
Bellos
N.
contributor
Blick
G.
contributor
Brar
I.
contributor
Dietz
C.
contributor
Dretler
R.
contributor
Elion
R.
contributor
Eron
J.
contributor
Feinberg
J.
contributor
Georgescu
G.
contributor
Scribner
A.
contributor
Hagins
D.
contributor
Henry
W.
contributor
Martorell
C.
contributor
Mayer
C.
contributor
McCurdy
L.
contributor
Mills
A.
contributor
Murphy
M.
contributor
Newman
C.
contributor
Ortiz
R.
contributor
Pierone
G.
contributor
Rana
A.
contributor
Saag
M.
contributor
Shalit
P.
contributor
Simon
G.
contributor
Sloan
L.
contributor
Stephens
J.
contributor
Tebas
P.
contributor
Towner
W.
contributor
Tribble
M.
contributor
Warner
D.
contributor
Wilkin
A.
contributor
Young
B.
contributor
article
2015
Lancet. Hiv
2352-3018
2352-3018
journal
2
4
e127-e136
Adolescent
Adult
Analysis of Variance
Anti-HIV Agents/administration & dosage
Darunavir/administration & dosage
Drug Administration Schedule
Drug Resistance, Viral/drug effects
Drug Therapy, Combination
Female
HIV Infections/drug therapy
HIV Infections/immunology
HIV-1
Heterocyclic Compounds, 3-Ring/administration & dosage
Humans
Male
Ritonavir/administration & dosage
Treatment Outcome
Viral Load/drug effects
eng
60_published
peer-reviewed